- Home
- BHVN vs PZZA Comparison
BHVN vs PZZA Comparison
Compare BHVN & PZZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- PZZA
- Stock Information
- Founded
- BHVN 2013
- PZZA 1984
- Country
- BHVN United States
- PZZA United States
- Employees
- BHVN N/A
- PZZA N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- PZZA Restaurants
- Sector
- BHVN Health Care
- PZZA Consumer Discretionary
- Exchange
- BHVN Nasdaq
- PZZA Nasdaq
- Market Cap
- BHVN 1.5B
- PZZA 1.4B
- IPO Year
- BHVN 2017
- PZZA 1993
- Fundamental
- Price
- BHVN $14.72
- PZZA $46.13
- Analyst Decision
- BHVN Strong Buy
- PZZA Buy
- Analyst Count
- BHVN 16
- PZZA 10
- Target Price
- BHVN $52.13
- PZZA $52.33
- AVG Volume (30 Days)
- BHVN 2.0M
- PZZA 1.1M
- Earning Date
- BHVN 11-11-2025
- PZZA 11-06-2025
- Dividend Yield
- BHVN N/A
- PZZA 3.99%
- EPS Growth
- BHVN N/A
- PZZA 8.47
- EPS
- BHVN N/A
- PZZA 2.28
- Revenue
- BHVN N/A
- PZZA $2,085,052,000.00
- Revenue This Year
- BHVN N/A
- PZZA $4.40
- Revenue Next Year
- BHVN $2,195.07
- PZZA $0.98
- P/E Ratio
- BHVN N/A
- PZZA $20.25
- Revenue Growth
- BHVN N/A
- PZZA N/A
- 52 Week Low
- BHVN $12.79
- PZZA $30.16
- 52 Week High
- BHVN $55.70
- PZZA $60.75
- Technical
- Relative Strength Index (RSI)
- BHVN 49.97
- PZZA 44.16
- Support Level
- BHVN $13.41
- PZZA $49.35
- Resistance Level
- BHVN $14.23
- PZZA $51.91
- Average True Range (ATR)
- BHVN 0.86
- PZZA 1.88
- MACD
- BHVN -0.17
- PZZA -0.21
- Stochastic Oscillator
- BHVN 33.98
- PZZA 2.03
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.